| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |